ALX Oncology Holdings Inc. Stock Performance

Open $1.18	Prev. Close $1.18	Circuit Range N/A
Day Range $1.18 - $1.28	Year Range $1.07 - $2.66	Volume 99,525
Average Traded $1.25

ALX Oncology Holdings Inc. Share Price Today

As of 11 October 2026, ALX Oncology Holdings Inc.'s share price is $1.26. The stock opened at $1.18, compared to its previous close of $1.18. During today's trading session, ALX Oncology Holdings Inc.'s share price traded between $1.18 and $1.28, with an average price of $1.23. Over the past 52 weeks, the stock has recorded a high of $2.66 and a low of $1.07. In terms of performance, ALX Oncology Holdings Inc.'s share price has declined by 25.88% over the last six months and is down 18.45% on a year-on-year basis.

ALX Oncology Holdings Inc. Share Price Chart

$1.18$1.28

ALX Oncology Holdings Inc. Stock Fundamentals & Key Indicators

Market Cap $67.61M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-0.58	Revenue (TTM) $0.00	Return On Equity (TTM) -59.40%
Profit Margin N/A	Debt to Equity 0.07	Quarterly Earnings Growth YoY 18.83%

ALX Oncology Holdings Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$22.14	-$22.85	-$17.93	-$17.97
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-3.21%	21.53%	-0.22%

ALX Oncology Holdings Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$123.48	-$160.81	-$134.85	-$101.70
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	-30.23%	16.14%	24.58%

About ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. It is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

ALX Oncology Holdings Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$1.38	$1.26	-9.32%
Sep 2026	$1.94	$1.40	-31.95%
Aug 2026	$1.99	$2.05	+5.40%
Jul 2026	$2.04	$1.95	-6.04%
Jun 2026	$1.86	$2.07	+7.81%
May 2026	$1.75	$1.92	+12.94%
Apr 2026	$2.05	$1.70	-15.21%
Mar 2026	$2.09	$2.00	-5.42%
Feb 2026	$1.66	$2.12	+21.49%
Jan 2026	$1.12	$1.75	+53.74%
Dec 2025	$1.38	$1.14	-16.85%
Nov 2025	$1.62	$1.36	-11.65%

ALXO Share Price FAQs

What is ALX Oncology Holdings Inc. share price today?

ALX Oncology Holdings Inc. share price today is $1.26 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of ALX Oncology Holdings Inc. stock?

The 52 week high of ALX Oncology Holdings Inc. stock is $2.66, while the 52 week low is $1.07 as of 10 Oct '26.

What is ALXO's market capitalisation today?

ALXO market capitalisation is $67.61M as of October 11, 2026, at 4:16 am IST.

What is ALXO's net income for the last quarter?

ALXO's net income for the last quarter is -17.97B USD.

What is the 5 year returns of ALXO?

The 5 year returns of ALXO is -97.74% as on 10 Oct '26.

What is the high & low stock price of ALXO today?

ALXO stock price hit a high of $1.28 and low of $1.18 as of 10 Oct '26.

Can I buy ALXO shares in India?

Yes. You can buy ALXO in India by opening an international trading account.